USC News highlighted work by Carl Kesselman and his team, who created DERIVA (Discovery Environment for Relational Information and Versioned Assets), a software program that collects data from microscopes and organizes it and other data into virtual photo albums that easily can be shared with other researchers. Their work is part of a three-study series published on Feb. 15 in the Journal of the American Society of Nephrology. (February 15, 2018)
Michelson Center faculty member Andrea Armani and Jonathan Lasch, of the Alfred E. Mann Institute for Biomedical Engineering, held a Facebook Live chat to talk about how technology is being used to transform healthcare and impact society. (February 13, 2018)
Daily Trojan reports that Agilent Technologies announced a new collaboration with the USC Michelson Center for Convergent Bioscience to develop an Agilent Center of Excellence in Biomolecular Characterization. The Agilent CoE, which will be housed in Michelson Hall, will provide students and local customers with access to scientific researchers, Agilent instrumentation and technologies all in one scientific environment. (January 30, 2018)
USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)
USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)
USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)
On Facebook Live, USC researchers Peter Kuhn, of the USC Michelson Center for Convergent Bioscience, and John Carpten, of Keck Medicine of USC’s Institute of Translational Genomics, discuss the connection between diversity and cancer research to enable personalized cancer treatment.
USC Viterbi writes that a team of USC researchers that developed a new material to self-regulate the temperature of a satellite, working in conjunction with a team at Northrop Grumman, will benefit from “the new capabilities in the recently-dedicated John D. O’Brien Nanofabrication Laboratory in the USC Michelson Center for Convergent Bioscience.”
The Viterbi Voices podcast featured Dr. Eun-Ji Chung, and talked to her about her research lab, which is involved in everything from “stem cell work, to nanomedicine, to highly specialized drug delivery techniques.”
The Viterbi Voices podcast featured Dr. Andrea Armani, and talked to her about her path to becoming a chemical engineering professor at USC, her interdisciplinary lab, and the USC Michelson Center for Convergent Bioscience. Dr. Armani’s lab will be moving to Michelson in December, and she will serve there as director of the cleanroom.